These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9328226)

  • 1. Effect of docarpamine, a novel orally active dopamine prodrug, on the formation of free and sulfoconjugated dopamine in patients who underwent cardiac surgery.
    Tano K; Yoshizumi M; Kitagawa T; Hori T; Kitaichi T; Itoh K; Katoh I
    Life Sci; 1997; 61(15):1469-78. PubMed ID: 9328226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of the dopamine prodrug docarpamine shortens need for drip infusion of dopamine in patients with low cardiac output syndrome after cardiac surgery.
    Matsubayashi K; Ueda Y; Ogino H; Sugita T; Sakakibara Y; Matsuyama K; Nomoto T
    Thorac Cardiovasc Surg; 1999 Dec; 47(6):352-6. PubMed ID: 10670791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of docarpamine on hemodynamics after open heart surgery in children.
    Watarida S; Shiraishi S; Sugita T; Katsuyama K; Nakajima Y; Yamamoto R; Yamamoto Y; Imura M; Hirokawa R; Mori A
    Ann Thorac Cardiovasc Surg; 2000 Apr; 6(2):106-9. PubMed ID: 10870004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentration and acute clinical effects of docarpamine, orally active dopamine prodrug, in infants.
    Tomita H; Fuse S; Chiba S
    Acta Paediatr Jpn; 1996 Oct; 38(5):440-3. PubMed ID: 8942000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a new orally active dopamine prodrug, docarpamine, on refractory ascites: a pilot study.
    Funasaki T; Tsutsumi M; Takase S; Tsuchishima M; Ueshima Y; Urashima S; Shimanaka K; Itoh T; Kawahara H
    Am J Gastroenterol; 1999 Sep; 94(9):2475-81. PubMed ID: 10484011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cardiorenal and emetic effects of dopamine prodrugs docarpamine (TA-870) and levodopa in dogs.
    Nishiyama S; Kanno K; Yamaguchi I
    J Pharmacobiodyn; 1991 Mar; 14(3):120-5. PubMed ID: 1679131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of dopamine prodrug, docarpamine.
    Yoshikawa M; Nishiyama S; Takaiti O
    Hypertens Res; 1995 Jun; 18 Suppl 1():S211-3. PubMed ID: 8529066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment for ovarian hyperstimulation syndrome using an oral dopamine prodrug, docarpamine.
    Tsunoda T; Shibahara H; Hirano Y; Suzuki T; Fujiwara H; Takamizawa S; Ogawa S; Motoyama M; Suzuki M
    Gynecol Endocrinol; 2003 Aug; 17(4):281-6. PubMed ID: 14503971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel orally active dopamine prodrug TA-870. I. Renal and cardiovascular effects and plasma levels of free dopamine in dogs and rats.
    Yamaguchi I; Nishiyama S; Akimoto Y; Yoshikawa M; Nakajima H
    J Cardiovasc Pharmacol; 1989 Jun; 13(6):879-86. PubMed ID: 2484082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in plasma free and sulfoconjugated catecholamines during the perioperative period of cardiac surgery: effect of continuous infusion of dopamine.
    Yoshizumi M; Kitagawa T; Ozawa Y; Tano K; Tsuchiya K; Houchi H; Minakuchi K; Tamaki T
    Biol Pharm Bull; 1998 Aug; 21(8):787-91. PubMed ID: 9743242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl) dopamine (TA-870) in humans.
    Yoshikawa M; Endo H; Komatsu K; Fujihara M; Takaiti O; Kagoshima T; Umehara M; Ishikawa H
    Drug Metab Dispos; 1990; 18(2):212-7. PubMed ID: 1971575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and dopamine after oral administration to rats and dogs.
    Yoshikawa M; Endo H; Komatsu K; Sugawara Y; Takaiti O
    J Pharmacobiodyn; 1990 Apr; 13(4):246-53. PubMed ID: 2384858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in plasma sulfoconjugated catecholamines during perioperative period of cardiac operations--effect of continuous infusion of dopamine].
    Yoshizumi M; Katoh I; Egawa Y; Kitagawa T; Miki O; Masuda Y; Ohuchi T; Oka M
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Feb; 40(2):194-201. PubMed ID: 1593158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel orally active dopamine prodrug TA-870. II. Evidence that TA-870 is a dopamine prodrug.
    Nishiyama S; Yamaguchi I; Akimoto Y; Yoshikawa M; Nakajima H
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):175-83. PubMed ID: 2476589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on the disposition of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and dopamine hydrochloride in rats and dogs.
    Yoshikawa M; Endo H; Otsuka M; Yamaguchi I; Harigaya S
    Drug Metab Dispos; 1988; 16(5):754-8. PubMed ID: 2906602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First pass metabolism and in vitro metabolism of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine in dogs.
    Yoshikawa M; Nishiyama S; Endo H; Togo Y; Takaiti O
    Drug Metab Dispos; 1991; 19(5):960-5. PubMed ID: 1686243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability and pharmacokinetics of an oral dopamine prodrug in dogs.
    Murata K; Noda K; Kohno K; Samejima M
    J Pharm Sci; 1989 Oct; 78(10):812-4. PubMed ID: 2600785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in plasma free and sulfoconjugated dopamine in patients with congenital heart disease who underwent cardiac operation.
    Yoshizumi M; Kitagawa T; Masuda Y; Hori T; Kitaichi T; Ogawa Y; Katoh I; Houchi H
    Jpn J Thorac Cardiovasc Surg; 1998 Aug; 46(8):651-6. PubMed ID: 9785858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deconjugating activity for sulfoconjugated dopamine in homogenates of organs from dogs.
    Yoshizumi M; Ohuchi T; Masuda Y; Katoh I; Oka M
    Biochem Pharmacol; 1992 Dec; 44(11):2263-5. PubMed ID: 1472090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological significance of plasma sulfoconjugated dopamine in patients with hypertension--clinical and experimental studies.
    Yoshizumi M; Kitagawa T; Hori T; Katoh I; Houchi H; Ohuchi T; Oka M
    Life Sci; 1996; 59(4):324-30. PubMed ID: 8761004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.